Request Call Back

Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Proton Pump Inhibitors

Proton Pump Inhibitors Side Effects Lawsuits | Side Effects: Femur Fractures, Hip Fractures, Spine Fractures, Wrist Fractures | Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex

Proton Pump Inhibitors Linked To Fractures Lawsuits

Proton Pump Inhibitors | Lawsuits, Lawyers | Side Effects: Fractures, Hip Fractures, Spine Fractures, Wrist Fractures | Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex

Have you experienced a fracture while taking Nexium, Prilosec, Prevacid? These heart burn drugs, known as proton pump inhibitors (PPIs), have been linked to an increased risk of fractures of the hip, wrist, and spine. In May 2010, the U.S. Food & Drug Administration (FDA) announced that it was revising the safety labels for both prescription and over-the-counter PPIs to reflect this risk.

Each year doctors write about 113.4 million prescriptions for PPIs to treat conditions like gastroesophageal reflux disease (GERD), stomach ulcers and other disorders. Even more people rely on over-the-counter (OTC) PPIs to deal with heart burn and stomach issues.  Our PPI fracture lawyers believe thousands of people may have suffered broken bones as a result of these popular medications. Yet most victims of PPI-related fractures probably have no idea that the drugs played a role in their injury.

If you broke your hip, wrist or spine while taking one of these medications, our PPI fracture lawyers want to hear from you. You may be entitled to compensation for your medical bills, lost wages, and pain and suffering. We urge you to contact us right away to protect your legal rights.

Proton Pump Inhibitors and Hypomagnesemia

The long-term use of proton pump inhibitors has been associated with hypomagnesemia, a condition caused by low levels of magnesium in the blood. In March 2011, the U.S. Food & Drug Administration (FDA) mandated that the makers of prescription proton pump inhibitors include information about the potential risk of low magnesium in the WARNINGS AND PRECAUTIONS sections of the labels for all prescription proton pump inhibitors. Proton pump inhibitors subjected to the new warnings included: Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, AcipHex, and Vimovo.

Low serum magnesium levels can result in serious adverse events including:
  • Muscle spasm
  • Arrhythmias (irregular heartbeat)
  • Seizures

According to the FDA, hypomagnesemia has been reported in adult patients taking proton pump inhibitors for at least three months, but most cases occurred after a year of treatment. Approximately one-quarter of these cases required discontinuation of proton pump inhibitor treatment in addition to magnesium supplementation. It is not understood why long-term proton pump inhibitor treatment sometimes results in hypomagnesemia. The FDA has recommended that healthcare providers consider obtaining serum magnesium levels before their patients begin treatment with prescription proto pump inhibitors. The agency said they should also consider periodic testing if patients are also being treated with medications such as digoxin, diuretics or drugs that may cause hypomagnesemia. In digoxin patients especially, low magnesium can increase the likelihood of serious side effects.

FDA Warning

PPIs work by reducing the amount of acid in the stomach. Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, and Vimovo are available by prescription to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus. Prilosec OTC, Zegerid OTC, and Prevacid 24HR are sold over-the-counter for the treatment of frequent heartburn.

For patients with chronic heart burn and other stomach problems, PPIs are a godsend. Unfortunately, long-term use of PPIs can come with a price. Several recent scientific studies found that people, especially women over 50, were more likely to suffer fractures, especially of the wrists, spine and hips, if they've also taken PPIs longer than a year.

According to an FDA Drug Safety Communication published in May 2010, these PPI studies used claims data from computerized administrative databases to evaluate the risk of fractures of the hip, wrist, and spine in patients treated with PPIs compared to individuals who were not using PPIs. The studies were generally six months in duration.

According to the FDA Drug Safety Communication, six studies reported an increased risk of fractures with the use of PPIs. Exposure to PPIs ranged from a period of 1 to 12 years, depending on the study. The emergence of fractures varied among studies; with one study reporting an increase in fractures with use of PPIs in the previous year and another study finding an increase after 5 to 7 years of PPI use.

The increased risk of fractures seen in the studies was primarily observed in older individuals. Two studies reported an increase in fractures with higher doses of PPI, and two studies reported an increase in fractures with longer duration of use.

According to the FDA, only one study did not find a relationship between PPI use and fractures. This study limited the subject population to those without major risk factors for fracture.

Following a review of these studies, the FDA decided to revise the Warnings and Precautions section of the prescription labeling as well as the OTC Drug Facts label for PPIs. The FDA has advised that health care professionals and consumers should weigh the known benefits against the potential risks of PPIs when determining if these medications are appropriate for treatment. Consumers also should talk with their health care professional about any concerns.

It is important that people using OTC versions of the medications read and follow the directions on the OTC Drug Facts label. According to the FDA, such PPIs should only be used as directed for 14 days for the treatment of frequent heartburn. No more than three 14-day treatment courses should be used in one year. If your heartburn continues, talk to your healthcare professional.

Legal Help for Victims of PPI Fractures

We offer a free case evaluation to victims of possible PPI-related fractures. If you or a loved one took a prescription PPI such as Nexium, Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, or Vimovo, we urge you to contact us today.

We also offer free consultations to fracture victims who took OTC versions of these drugs, including Prilosec OTC, Zegerid OTC, and Prevacid 24HR. Please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) to discuss your case with one of our PPI fracture lawyers today.


Proton Pump InhibitorsRSS Feed

Application Filed for Multidistrict Litigation Over PPIs

Jun 2, 2017
Seven Proton Pump Inhibitors and Five Drug Makers Involved in Litigation On May 31, 2017 an application was filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to create a multidistrict litigation (MDL) in either the District of New Jersey or, alternatively, the Southern District Court of Illinois for the Proton Pump Inhibitor (PPI) cases that allege that taking a PPI as prescribed by a physician or recommended by a healthcare professional, led to kidney injuries. Alleged...

Inadequate Warnings of Serious Side Effects of Proton Pump Inhibitors

Feb 8, 2017
Millions of Americans suffer from heartburn, acid reflux and similar digestive conditions and many of them take a proton pump inhibitor (PPI) medication to provide relief from the condition. PPIs ease heartburn and acid reflux by causing the stomach to produce less acid. But these medications can have serious side effects, as has been shown by research and indicated by mounting lawsuits against the makers of PPIs. A number of these lawsuits have been consolidated in a multidistrict...

Heartburn Drugs Linked to Gastroenteritis

Jan 13, 2017
A recent study conducted by scientists from the Australian National University (ANU) found that people who use heartburn drugs, such as proton pump inhibitors (PPIs), have a 70 percent increased chance of developing infectious gastroenteritis. ANU Study Findings Dr. Yingxi Chen led the research at ANU that discovered the connection between the heartburn medications and gastroenteritis, often called gastro. The illness, that may require hospitalization, causes over 13...

Heartburn Med Taken with Antibiotic May Cause Irregular Heartbeat

Dec 9, 2016
Many people suffering from heartburn and similar conditions take acid-reducing drugs called proton pump inhibitors (PPIs). According to a new study, researchers from Columbia University Medical Center and the Data Science Institute at Columbia University found that the popular PPI heartburn drug, Prevacid (lansoprazole), when taken together with an antibiotic, ceftriaxone, could increase the risk for a dangerous condition known as long QT syndrome. Long QT syndrome is a heart rhythm condition...

Kidney Failure Among Potential Nexium Side Effects

Sep 21, 2016
PPI Used To Stomach Acid  Link To Kidney Failure Nexium (esomeprazole) is a proton pump inhibitor (PPI) manufactured by AstraZeneca that is used to treat gastric hyperacidity, as well as reflux, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome (ZES), peptic ulcers, and heartburn. Although used by millions of people in the United States to reduce stomach acid (hydrochloric acid) production, studies suggests that Nexium may be associated with kidney failure. A study...

More Proton Pump Inhibitors News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo